Black Rock Inc. Kiromic Biopharma, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.87 $8,982 - $30,055	-34,547 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.6 - $1.82 $1,026 - $3,112	-1,710 Reduced 4.72%	34,547 $30,000
Q4 2021 Feb 10, 2022	BUY	$1.53 - $3.12 $8,586 - $17,509	5,612 Added 18.31%	36,257 $55,000
Q3 2021 Nov 09, 2021	BUY	$2.69 - $4.94 $56,538 - $103,828	21,018 Added 218.32%	30,645 $94,000
Q2 2021 Aug 11, 2021	BUY	$4.81 - $10.34 $46,305 - $99,543	9,627 New	9,627 $46,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $22.2M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.